PMID- 17291499 OWN - NLM STAT- MEDLINE DCOM- 20070626 LR - 20201209 IS - 0014-4886 (Print) IS - 0014-4886 (Linking) VI - 204 IP - 2 DP - 2007 Apr TI - Chronic alcohol consumption alters mammalian target of rapamycin (mTOR), reduces ribosomal p70s6 kinase and p4E-BP1 levels in mouse cerebral cortex. PG - 840-4 AB - Reduced insulin sensitivity following chronic alcohol consumption may contribute to alcohol-induced brain damage although the underlying mechanism(s) has not been elucidated. This study was designed to examine the effect of chronic alcohol intake on insulin signaling in mouse cerebral cortex. FVB mice were fed with a 4% alcohol diet for 16 weeks. Insulin receptor substrates (IRS-1, IRS-2) and post-receptor signaling molecules Akt, mammalian target of rapamycin (mTOR), ribosomal p70s6 kinase (p70s6k) and the eukaryotic translation initiation factor 4E (eIF4E)-binding protein 1 (4E-BP1) as well as the apoptotic marker caspase-3 were evaluated using Western blot analysis. Chronic alcohol intake significantly dampened whole body glucose tolerance, enhanced expression of caspase-3 and mTOR, reduced p70s6k and 4E-BP1 with little effect on Akt signaling in alcohol-consuming mice. These data suggest that chronic alcohol intake may contribute to cerebral cortex dysfunction through mechanisms related, at least in part, to dampened post insulin receptor signaling at the levels of mTOR, p70s6k and 4E-BP1. FAU - Li, Qun AU - Li Q AD - Division of Pharmaceutical Sciences, Center for Cardiovascular Research and Alternative Medicine and Graduate Neuroscience Program, University of Wyoming, Laramie, WY 82071, USA. FAU - Ren, Jun AU - Ren J LA - eng GR - R01 AA013412/AA/NIAAA NIH HHS/United States GR - R15 AA013575/AA/NIAAA NIH HHS/United States GR - 1R01 AA 013412-01A2/AA/NIAAA NIH HHS/United States GR - 1R15 AA/HL 13575-01/AA/NIAAA NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20070113 PL - United States TA - Exp Neurol JT - Experimental neurology JID - 0370712 RN - 0 (Adaptor Proteins, Signal Transducing) RN - 0 (Alcohols) RN - 0 (Carrier Proteins) RN - 0 (Cell Cycle Proteins) RN - 0 (Eif4ebp1 protein, mouse) RN - 0 (Eukaryotic Initiation Factors) RN - 0 (Phosphoproteins) RN - EC 2.7.11.1 (Ribosomal Protein S6 Kinases, 70-kDa) RN - EC 3.4.22.- (Caspase 3) RN - W36ZG6FT64 (Sirolimus) SB - IM MH - Adaptor Proteins, Signal Transducing MH - Alcohol Drinking/*metabolism MH - Alcohols/administration & dosage MH - Analysis of Variance MH - Animals MH - Carrier Proteins/*metabolism MH - Caspase 3/metabolism MH - Cell Cycle Proteins MH - Cerebral Cortex/drug effects/*metabolism MH - Eukaryotic Initiation Factors MH - Glucose Tolerance Test/methods MH - Male MH - Mice MH - Phosphoproteins/*metabolism MH - Ribosomal Protein S6 Kinases, 70-kDa/*metabolism MH - Sirolimus/*metabolism PMC - PMC1895598 MID - NIHMS21543 EDAT- 2007/02/13 09:00 MHDA- 2007/06/27 09:00 PMCR- 2008/04/01 CRDT- 2007/02/13 09:00 PHST- 2006/11/03 00:00 [received] PHST- 2006/12/20 00:00 [revised] PHST- 2007/01/08 00:00 [accepted] PHST- 2007/02/13 09:00 [pubmed] PHST- 2007/06/27 09:00 [medline] PHST- 2007/02/13 09:00 [entrez] PHST- 2008/04/01 00:00 [pmc-release] AID - S0014-4886(07)00025-8 [pii] AID - 10.1016/j.expneurol.2007.01.005 [doi] PST - ppublish SO - Exp Neurol. 2007 Apr;204(2):840-4. doi: 10.1016/j.expneurol.2007.01.005. Epub 2007 Jan 13.